Silver Book

Silver Book Fact

>1/2 of flu’s economic burden from people 65+

An estimated 64% of the total economic burden of influenza comes from those over 65 years old.

Molinari, Noelle-Angelique M., Ismael R. Ortega-Sanchez, Mark L. Messonnier, William W. Thompson, Pascale M. Wortley, et al. The Annual Impact of Seasonal Influenza in the U.S.: Measuring disease burden and costs. Vaccine. 2007; 25: 5086-96. http://download.thelancet.com/flatcontentassets/H1N1-flu/epidemiology/epidemiology-14.pdf

Reference

Title
The Annual Impact of Seasonal Influenza in the U.S.: Measuring disease burden and costs
Publication
Vaccine
Publication Date
2007
Authors
Molinari, Noelle-Angelique M., Ismael R. Ortega-Sanchez, Mark L. Messonnier, William W. Thompson, Pascale M. Wortley, et al.
Pages
5086-96
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Sepsis accounts for nearly 1/2 of ICU expenditures
    Infection and related sepsis/septicemia account for 40% of all ICU expenditures.  
  • Antibiotic resistance of Klebsiella pneumoniae on the rise
    Resistance of Klebsiella pneumoniae to antibiotics has dramatically increased- from 5.3% to 11.6% for third generation cephalosporins (between 1999 and 2010), and from <0.1% to 4.5% for carbapenams (between 2002…  
  • Medical expenses for Medicare patients with pneumonia higher
    Medicare patients hospitalized for pneumonia have medical expenses—during the hospitalization and for a year afterwards—that are $15,682 higher than in Medicare patients without pneumonia.  
  • Mortality from vaccine-preventable diseases
    Vaccine-preventable diseases or their complications account for 50,000 to 90,000 adult deaths in the U.S. each year.  
  • Around $35 billion cost to society from antibiotic resistant infections
    The societal costs of antibiotic resistant infections are around $35 billion each year- this includes the cost of lost wages and premature deaths.